Actively Recruiting
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
Led by European University of Madrid · Updated on 2025-02-21
26
Participants Needed
2
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if virtual reality combined with conventional physiotherapy intervention works to treat moderate to severe multiple sclerosis persons. The main questions it aims to answer are: * Does the application of a virtual reality-based program along with conventional physiotherapy produces improvements compared to the application of conventional physiotherapy and placebo virtual reality in motor aspects of patients with multiple sclerosis? * Does the application of a virtual reality-based program along with conventional physiotherapy produces improvements compared to the application of conventional physiotherapy and placebo virtual reality in cognitive aspects of patients with multiple sclerosis Researchers will compare a virtual reality-based program along with conventional physiotherapy with a placebo virtual reality to see if virtual reality improve motor and cognitive aspects of multiple sclerosis. Participants will: * Visit the clinic twice a week for 10 weeks to receive a 1-hour session of virtual reality and conventional physiotherapy. * Be assessed using various scales and questionnaires at three different times: at the start of the study, at the end of the treatment, and 4 weeks after the study ends.
CONDITIONS
Official Title
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of Multiple Sclerosis based on McDonald criteria with disease duration over two years
- Multiple Sclerosis Disability Status Scale (EDSS) score of 6.5 or higher, indicating need for two types of support to walk about 20 meters without resting
- Stable medical treatment for at least six months before starting the intervention
- No cognitive impairment, with ability to understand instructions and a Mini-Mental Test score of 24 or higher
You will not qualify if you...
- Diagnosis of other neurological or musculoskeletal disorders besides Multiple Sclerosis
- Diagnosis of cardiovascular, respiratory, metabolic diseases, or other conditions that could interfere with the study
- Exacerbation or hospitalization within 3 months before starting the study or during the treatment period
- Use of steroids (oral or intravenous) within 6 months before or during the study intervention
- Visual problems not corrected by glasses or other ocular devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Asociación Mostoleña de Esclerosis Múltiple (AMDEM)
Móstoles, Madrid, Spain, 28933
Actively Recruiting
2
Fundación Esclerosis Multiple Madrid (FEMM)
Madrid, Spain, 28003
Actively Recruiting
Research Team
M
Marina Castel-Sánchez, PhD
CONTACT
A
Alberto Bermejo-Franco, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here